Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Neuronetics, Inc. (STIM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
6.43+0.04 (+0.63%)
At close: 04:00PM EST
6.72 +0.29 (+4.51%)
After hours: 07:57PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.39
Open6.38
Bid6.20 x 800
Ask6.50 x 900
Day's Range6.33 - 6.63
52 Week Range1.98 - 6.95
Volume247,811
Avg. Volume234,665
Market Cap175.034M
Beta (5Y Monthly)2.04
PE Ratio (TTM)N/A
EPS (TTM)-1.46
Earnings DateMar 06, 2023 - Mar 10, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Neuronetics Inks Six-Year Exclusive Partnership With Greenbrook TMS

    Neuronetics Inc (NASDAQ: STIM) and Greenbrook TMS Inc (NASDAQ: GBNH) announced an expanded commercial partnership through year-end 2028. Under the partnership agreement, Neuronetics will be the exclusive supplier of transcranial magnetic stimulation (TMS) equipment to Greenbrook. Over time, Neuronetics' NeuroStar devices will replace competitive TMS devices at Greenbrook locations. The agreement also has minimum purchase commitments, and all treatment session purchases will convert to a "per-cli

  • GlobeNewswire

    Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership

    MALVERN, Pa. and TORONTO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders (“Neuronetics”), and Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH), a leading provider of transcranial magnetic stimulation (“TMS”) therapy (“Greenbrook”), today announced an expanded commercial partnership thro

  • GlobeNewswire

    Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    MALVERN, Pa., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards to three new non-executive employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the award was approved by Neuronetics’ Compensation Committee and made as a material induce

Advertisement
Advertisement